Anti-ELOC monoclonal antibody

Pre-made anti-ELOC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ELOC/ELOC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2473-Ab-1/ GM-Tg-hg-IP2473-Ab-2Anti-Human ELOC monoclonal antibodyHuman
GM-Tg-rg-IP2473-Ab-1/ GM-Tg-rg-IP2473-Ab-2Anti-Rat ELOC monoclonal antibodyRat
GM-Tg-mg-IP2473-Ab-1/ GM-Tg-mg-IP2473-Ab-2Anti-Mouse ELOC monoclonal antibodyMouse
GM-Tg-cynog-IP2473-Ab-1/ GM-Tg-cynog-IP2473-Ab-2Anti-Cynomolgus/ Rhesus macaque ELOC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2473-Ab-1/ GM-Tg-felg-IP2473-Ab-2Anti-Feline ELOC monoclonal antibodyFeline
GM-Tg-cang-IP2473-Ab-1/ GM-Tg-cang-IP2473-Ab-2Anti-Canine ELOC monoclonal antibodyCanine
GM-Tg-bovg-IP2473-Ab-1/ GM-Tg-bovg-IP2473-Ab-2Anti-Bovine ELOC monoclonal antibodyBovine
GM-Tg-equg-IP2473-Ab-1/ GM-Tg-equg-IP2473-Ab-2Anti-Equine ELOC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2473-Ab-1/ GM-Tg-hg-IP2473-Ab-2; GM-Tg-rg-IP2473-Ab-1/ GM-Tg-rg-IP2473-Ab-2;
GM-Tg-mg-IP2473-Ab-1/ GM-Tg-mg-IP2473-Ab-2; GM-Tg-cynog-IP2473-Ab-1/ GM-Tg-cynog-IP2473-Ab-2;
GM-Tg-felg-IP2473-Ab-1/ GM-Tg-felg-IP2473-Ab-2; GM-Tg-cang-IP2473-Ab-1/ GM-Tg-cang-IP2473-Ab-2;
GM-Tg-bovg-IP2473-Ab-1/ GM-Tg-bovg-IP2473-Ab-2; GM-Tg-equg-IP2473-Ab-1/ GM-Tg-equg-IP2473-Ab-2
Products NameAnti-ELOC monoclonal antibody
Formatmab
Target NameELOC
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ELOC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2473-Ag-1Recombinant multi-species ELOC/ SIII/ TCEB1 protein


    Target information

    Target IDGM-IP2473
    Target NameELOC
    Gene ID6921,67923,64525,698922,477914,100628309,540859,100060902
    Gene Symbol and Synonyms2610043E24Rik,2610301I15Rik,ELOC,SIII,TCEB1
    Uniprot AccessionQ15369,P83941,Q2KII4
    Uniprot Entry NameELOC_HUMAN,ELOC_RAT,ELOC_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000154582
    Target ClassificationN/A

    The target: ELOC, gene name: ELOC, also named as SIII, TCEB1. This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been identified. [provided by RefSeq, Mar 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.